Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
MRK, Daiichi Begin Pivotal Esophageal Cancer Study With ADC Drug
11:26am, Tuesday, 20'th May 2025
The IDeate-Esophageal01 study is set to evaluate Merck & Daiichi's ADC drug ifinatamab deruxtecan in pre-treated patients with esophageal squamous cell carcinoma.
I'm Putting Cash To Work: 2 Rock-Solid Dividends At Bargain Prices
11:36am, Monday, 19'th May 2025
I'm targeting value in overlooked sectors, highlighting Merck and Federal Realty as top picks for income and upside potential. Merck offers a low 8.5x PE, a 4.3% yield, a robust drug pipeline, and res
5 Worry-Free Dividend Stocks Investors Can Buy Now and Hold Forever
10:00am, Monday, 19'th May 2025
There are over 12,000 publicly traded stocks in the United States; not even the most intelligent investors with the best tools can immediately find them. Many investors and traders typically maintain
PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?
09:30am, Monday, 19'th May 2025
Both PFE and MRK have strong product and pipeline portfolios in oncology.
5 Worry-Free Dividend Stocks Investors Can Buy Now and Hold Forever
06:47am, Saturday, 17'th May 2025
There are over 12,000 publicly traded stocks in the United States; not even the most intelligent investors with the best tools can immediately find them. Many investors and traders typically maintain
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new clinical and outcomes research data on pulmonary arterial hypertension (PAH)
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Positive Topline Results of Phase 3 KEYNOTE-B96 Trial In Patients With Platinum-Resistant Recurrent Ovarian Cancer.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--WELIREG PPGL FDA Approval News Release.
Merck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference (Transcript)
04:50pm, Wednesday, 14'th May 2025
Merck & Co., Inc. (NYSE:MRK ) BofA Securities 2025 Healthcare Conference May 14, 2025 1:40 PM ET Company Participants Jannie Oosthuizen - President Peter Dannenbaum - Senior Vice President, Investor R
US FDA expands use of Merck's cancer drug for adrenal gland tumors
12:48pm, Wednesday, 14'th May 2025
The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two types adrenal gland tumors.
3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows
11:31am, Wednesday, 14'th May 2025
Buying low and selling high is what investing comes down to. Often, however, investors get spooked when prices are low and avoid struggling stocks, thinking that they are destined to go even lower.
Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
09:55am, Wednesday, 14'th May 2025
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen next.
Germany's Merck drops China surcharge on orders after US-China tariff deal
08:46am, Wednesday, 14'th May 2025
German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on each other, the com
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
08:40am, Tuesday, 13'th May 2025
President Trump issues an executive order that will push drugmakers to offer prescription drugs to U.S. cash-pay consumers at lower prices.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research across more than 25 types of cancer and multiple trea
